MedPath

Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS)

Not Applicable
Conditions
Endometrioma
Interventions
Procedure: stripping technique
Procedure: ethanol sclerotherapy
Registration Number
NCT04178876
Lead Sponsor
Catholic University of the Sacred Heart
Brief Summary

The aim of this study is to compare two different laparoscopic surgical techniques (endometrioma stripping vs ethanol sclerotherapy) in terms of ovarian reserve (AMH levels), recurrence rate and pain relief.

Detailed Description

Patients with pelvic pain (VAS score≥4) and ultrasound diagnosis of endometrioma \> 4cm candidate to surgical removal of endometrioma will be randomized into 2 group. One Group will undergo laparoscopical stripping technique; the other one will undergo laparoscopic aspiration and sclerotherapy using 95% ethanol.

The women will be introduced with both operative options and they will be informed about the randomization . After an elaborate explanation about the study they will sign an informed consent form. the following data will be collected prior the operation: age, gravity \& parity, operative history, general medical history, the cyst size, AMH (Anti Mullerian Hormone), symptoms related to endometriosis (through VAS score), fertility history including any fertility treatment in the past and planned pregnancy after the operation.

The laparoscopy will take place in Fondazione Policlinico Gemelli IRCSS, Roma. in the study group the cyst content will be aspirated and flushed with normal saline. 95% sterile ethanol will be instilled into the cyst through a Nelathon catheter. Ethanol will be left in the cyst for 15 min then aspirated as completely as possible following normal saline flushing. In the control group we will follow the standard treatment which is cystectomy.

The women will be followed at 1 , 3 , 6 and 12 months after the surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
64
Inclusion Criteria
  • Women between 18-35 years old
  • Women with ultrasound diagnosis of ovarian endometrioma ≥4cm (with or without deep infiltrating endometriosis)
  • History of dysmenorrhea and/or chronic pelvic pain
  • candidates for elective laparoscopy due to endometriosis.
Exclusion Criteria
    • Previous surgery for ovarian endometriosis
  • Evidence of premature ovarian failure (follicle stimulating hormone ≥40 international units/L)
  • Endocrinal disorders that might affect ovarian function (e.g., polycystic ovary syndrome, thyroid dysfunction, hyperprolactinemia)
  • Ultrasound suspicious of ovarian malignant disease according IOTA criteria
  • endometrial cyst < 4 cm. • ethanol sensitivity.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
laparoscopic stripping techniquestripping techniquecystectomy of endometriomas during laparoscopy
Aspiration and Sclerotherapy of endometriomasethanol sclerotherapyAspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas
Primary Outcome Measures
NameTimeMethod
impact on ovarian reserve, in terms of reduction of serum AMH levelsup to 12 months after the laparoscopy

The AMH levels will be evaluated 1 month before the surgery and 1, 6 and 12 months after surgery.

Secondary Outcome Measures
NameTimeMethod
endometrioma recurrence rate for the two surgical techniquesup to 12 months after the laparoscopy

Ultrasound examination that demonstrate the presence/lack of ovarian cyst with sonographic features of endometrioma in the ovary where the procedure took place.

pain relief after surgeryup to 12 months after the laparoscopy

The severity of pelvic pain , assessed using a visual analogue scale with no-pain classified as 0 and worst imaginable pain as 10.

Trial Locations

Locations (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath